The Role and Function of Ras-association domain family in Cancer : A Review
© 2019 Chongqing Medical University. Production and hosting by Elsevier B.V..
Ras gene mutation has been observed in more than 30% of cancers, and 90% of pancreatic, lung and colon cancers. Ras proteins (K-Ras, H-Ras, N-Ras) act as molecular switches which are activated by binding to GTP. They play a role in the cascade of cell process control (proliferation and cell division). In the inactive state, transforming GTP to GDP leads to the activation of GTpase in Ras gene. However, the mutation in Ras leads to the loss of internal GTPase activity and permanent activation of the protein. The activated Ras can promote the cell death or stop cell growth, which are facilitated by Ras-association domain family. Various studies have been conducted to determine the importance of losing RASSF proteins in Ras-induced tumors. This paper examines the role of Ras and RASSF proteins. In general, RASSF proteins can be used as a suitable means for targeting a large group of Ras-induced tumors.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Genes & diseases - 6(2019), 4 vom: 19. Dez., Seite 378-384 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zinatizadeh, Mohammad Reza [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer |
|---|
| Anmerkungen: |
Date Revised 01.10.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.gendis.2019.07.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM304336734 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM304336734 | ||
| 003 | DE-627 | ||
| 005 | 20231225114752.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.gendis.2019.07.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1014.xml |
| 035 | |a (DE-627)NLM304336734 | ||
| 035 | |a (NLM)31832517 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zinatizadeh, Mohammad Reza |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Role and Function of Ras-association domain family in Cancer |b A Review |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.10.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2019 Chongqing Medical University. Production and hosting by Elsevier B.V. | ||
| 520 | |a Ras gene mutation has been observed in more than 30% of cancers, and 90% of pancreatic, lung and colon cancers. Ras proteins (K-Ras, H-Ras, N-Ras) act as molecular switches which are activated by binding to GTP. They play a role in the cascade of cell process control (proliferation and cell division). In the inactive state, transforming GTP to GDP leads to the activation of GTpase in Ras gene. However, the mutation in Ras leads to the loss of internal GTPase activity and permanent activation of the protein. The activated Ras can promote the cell death or stop cell growth, which are facilitated by Ras-association domain family. Various studies have been conducted to determine the importance of losing RASSF proteins in Ras-induced tumors. This paper examines the role of Ras and RASSF proteins. In general, RASSF proteins can be used as a suitable means for targeting a large group of Ras-induced tumors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Colon | |
| 650 | 4 | |a H-Ras | |
| 650 | 4 | |a K-Ras | |
| 650 | 4 | |a Lung | |
| 650 | 4 | |a N-Ras | |
| 650 | 4 | |a Pancreatic | |
| 700 | 1 | |a Momeni, Seyed Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Zarandi, Peyman Kheirandish |e verfasserin |4 aut | |
| 700 | 1 | |a Chalbatani, Ghanbar Mahmoodi |e verfasserin |4 aut | |
| 700 | 1 | |a Dana, Hassan |e verfasserin |4 aut | |
| 700 | 1 | |a Mirzaei, Hamid Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Akbari, Mohammad Esmaeil |e verfasserin |4 aut | |
| 700 | 1 | |a Miri, Seyed Rouhollah |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Genes & diseases |d 2014 |g 6(2019), 4 vom: 19. Dez., Seite 378-384 |w (DE-627)NLM242912818 |x 2352-3042 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2019 |g number:4 |g day:19 |g month:12 |g pages:378-384 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gendis.2019.07.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2019 |e 4 |b 19 |c 12 |h 378-384 | ||